Replies to post #13428 on SARS Corp.(fka SARO)

[Reality2]

The SEC's complaint alleges that Cheung hired Bingham on Otto's recommendation, and they embarked on an aggressive public relations campaign that centered on the misleading promotion of two key products - "Restorade" and "Stamina Solutions" - that did not exist. They developed promotional materials that falsely stated that both Restorade and Stamina Solution are "[a]vailable as functional beverage or as a soft gel capsule." To accompany the written text of MitoPharm's Web site and other promotional materials, Cheung had a graphics artist create renderings of what the containers for MitoPharm's products could look like. Written materials and Web profiles created by Bingham and others were disseminated to investors with fake images and present-tense descriptions of the products.